| 000 | 01241 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517023138.0 | ||
| 264 | 0 | _c20150407 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2015.1444 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Tongyu | |
| 245 | 0 | 0 |
_aTreatment to prevent hepatitis B virus reactivation in patients with lymphoma receiving chemotherapy--reply. _h[electronic resource] |
| 260 |
_bJAMA _c |
||
| 300 |
_a1270 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHepatitis B _xprevention & control |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamivudine _xtherapeutic use |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 700 | 1 | _aHuang, He | |
| 700 | 1 | _aLi, Xueying | |
| 773 | 0 |
_tJAMA _gvol. 313 _gno. 12 _gp. 1270 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2015.1444 _zAvailable from publisher's website |
| 999 |
_c24736685 _d24736685 |
||